SCHEMBL13507094

SCHEMBL13507094

Cn1c2cc(N(c3ccc(C(C)(C)C)cc3)c3ccc(C(C)(C)C)cc3)ccc2c2c3ccc4c(c3ccc21)c1ccc(N(c2ccc(C(C)(C)C)cc2)c2ccc(C(C)(C)C)cc2)cc1n4C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 3/20 0.35
▸ ALDH1A1 P00352 5/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ HPGD P15428 3/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ MAPT P10636 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ PGR P06401 1/20 0.32
▸ RORA P35398 1/20 0.32
▸ RORC P51449 1/20 0.32
▸ RORB Q92753 1/20 0.32
▸ HTR1D P28221 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ APOBEC3G Q9HC16 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507026 0.95 KIF11 (0.38) KIF11ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13507554 0.85 KIF11 (0.38) KIF11ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13506831 0.83 ALDH1A1 (0.35) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL13506824 0.83 NQO2 (0.38) KIF11ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL13508019 0.82 KIF11 (0.37) KIF11ALDH1A1KDM4EMAPTNPSR1
SCHEMBL13506801 0.80 ALDH1A1 (0.39) KIF11ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24713746 0.80 MAPK1 (0.34) KIF11ALDH1A1KDM4EHSD17B10MAPT
SCHEMBL25561276 0.80 MAPK1 (0.34) KIF11ALDH1A1KDM4EHSD17B10MAPT
SCHEMBL26444952 0.80 MAPK1 (0.34) KIF11ALDH1A1KDM4EHSD17B10MAPT
SCHEMBL26444931 0.79 NPSR1 (0.34) KIF11ALDH1A1KDM4EMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 KIF11 2078/4885ALDH1A1 119/4885KDM4E 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback